For many homeowners, the past few years have felt like a tug-of-war between soaring property values and rising financial pressures. In 2025, this tension has only intensified. Interest rates remain ...

For Reuters Pharma Europe 2025, pharmaphorum is providing coverage courtesy NAVLIN Daily, a pricing and market access insights report from EVERSANA (pharmaphorum's parent company). You can see the ...